| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000270062.1 |
AKT inhibitor VIII |
Lung squamous cell carcinoma |
0.002409494 |
Resistant |
| ENSG00000270062.1 |
AKT inhibitor VIII |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031039072 |
Sensitive |
| ENSG00000270062.1 |
AKT inhibitor VIII |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044850317 |
Sensitive |
